Table 1 Demographics of the cohorts

Age (average)

56.7 (10–90)

Overall survival (months, 95% C.I.)

69.3 (55.0–83.5)

Histotype

 High grade serous carcinoma

42

(15.2%)

 Low grade serous carcinoma

10

(3.6%)

 Clear cell carcinoma

24

(8.7%)

 Mucinous

10

(3.6%)

 Endometrioid

13

(4.7%)

 Malignant germ cell tumor

2

(0.7%)

 Others*

176

(63.5%)